Leong Hup International Berhad (6633)
Kuala Lumpur Exchange · Malaysia · prices in MYR · close of 23 Oct 2026
Key indicators
| Last close | MYR 0.710 |
|---|---|
| 52-week range | 0.620 – 0.835 |
| Return, 1 month / 3 months | −1.4% / −5.3% |
| Return, 1 year / 3 years | +9.5% / +31.9% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 25.2% |
| Worst drawdown (1 year) | -15.2% |
| Average daily value traded | 1.44M MYR |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Leong Hup International Berhad is a Malaysian poultry and livestock group based in Kuala Lumpur. It produces animal feed, runs broiler and layer farms, and processes and distributes poultry products such as chicken and eggs, along with related food items. Its customers include food manufacturers, retailers, food service operators and households, and its products reach markets across Malaysia and other parts of Southeast Asia.
On this site Leong Hup International Berhad appears as a stock on the Kuala Lumpur Exchange (Malaysia), code 6633, with prices in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Leong Hup International Berhad (6633) trades on the Kuala Lumpur Exchange in Malaysia. It last closed at MYR 0.710 on 23 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 245 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.5% and over the last three months it fell 5.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Kuala Lumpur Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -4.3% | ||
| From 52-week high | -13.4% | ||
| Momentum | 59 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -5.3% | ||
| 6-month return | -1.4% | ||
| 12-month return, skipping the last month | 11.1% | ||
| Stability (higher is calmer) | 84 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 25.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -15.2% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 1.44M MYR | ||
| Zero-volume days | 1.7% | ||
| Income | 39 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 4 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −1.4% |
| 3 months | −5.3% |
| 6 months | −1.4% |
| 1 year | +9.5% |
| 3 years | +31.9% |
| 5 years | +22.2% |
Signals
| 50-day / 200-day average | 0.740 / 0.742 |
|---|---|
| Golden / death cross (60 days) | Death, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.018 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Sep 2026 | MYR 0.0150 |
| 22 Jan 2026 | MYR 0.0100 |
| 13 Jun 2025 | MYR 0.0100 |
| 10 Dec 2024 | MYR 0.0145 |
| 14 May 2024 | MYR 0.0130 |
| 11 Jan 2024 | MYR 0.0120 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Kuala Lumpur Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.